Predictions
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€450.10
28.02.23
28.02.23
€569.31
28.02.24
28.02.24
1.53%
29.02.24
29.02.24
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€450.10
28.02.23
28.02.23
€569.31
28.02.24
28.02.24
1.53%
29.02.24
29.02.24
Henry Schein Inc.
Start price
Target price
Perf. (%)
€74.17
28.02.23
28.02.23
€91.27
28.02.24
28.02.24
-4.57%
29.02.24
29.02.24
Henry Schein Inc.
Start price
Target price
Perf. (%)
€74.17
28.02.23
28.02.23
€91.27
28.02.24
28.02.24
-4.57%
29.02.24
29.02.24
Addus Homecare Corp.
Start price
Target price
Perf. (%)
€100.00
28.02.23
28.02.23
-
28.02.24
28.02.24
-16.50%
29.02.24
29.02.24
Orpea Nom.
Start price
Target price
Perf. (%)
€2.58
20.02.23
20.02.23
-
20.02.24
20.02.24
-1.16%
05.03.23
05.03.23
Could be very worthwhile Investment >20% year
Orpea Nom.
Start price
Target price
Perf. (%)
€2.17
08.02.23
08.02.23
-
08.02.24
08.02.24
-9.35%
03.04.23
03.04.23
Could be very worthwhile Investment >20% year
Orpea Nom.
Start price
Target price
Perf. (%)
€2.36
07.02.23
07.02.23
€4.00
07.02.24
07.02.24
9.32%
18.02.23
18.02.23
Could be very worthwhile Investment >20% year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Orpea Nom.
Start price
Target price
Perf. (%)
€2.87
05.02.23
05.02.23
-
05.02.24
05.02.24
-10.07%
18.02.23
18.02.23
Could be very worthwhile Investment >20% year
Sientra Inc.
Start price
Target price
Perf. (%)
€1.84
02.02.23
02.02.23
€3.60
02.02.24
02.02.24
-4.62%
06.02.23
06.02.23
Could be very worthwhile Investment >20% year
Orpea Nom.
Start price
Target price
Perf. (%)
€5.54
01.02.23
01.02.23
-
01.02.24
01.02.24
-48.21%
05.02.23
05.02.23
Could be very worthwhile Investment >20% year
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€2.16
10.01.23
10.01.23
€4.00
31.12.25
31.12.25
-46.57%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€43.10
09.01.23
09.01.23
-
09.01.24
09.01.24
-0.35%
21.01.23
21.01.23
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
HTG Molecular Diagnostics Inc.
Start price
Target price
Perf. (%)
€3.79
27.12.22
27.12.22
-
27.12.23
27.12.23
-90.75%
29.07.23
29.07.23
Capable Management
Risky Investment
No uniques
No Innovation
HTG Molecular Diagnostics Inc.
Start price
Target price
Perf. (%)
€19.20
12.12.22
12.12.22
€0.000
12.12.23
12.12.23
-63.50%
15.12.22
15.12.22
Capable Management
Risky Investment
No uniques
No Innovation